FDA Approves New Pancreatic Cancer Treatment

Why it matters locally: This national approval means New Hampshire residents suffering from pancreatic cancer will have access to a new treatment option through their healthcare providers.

U.S. health officials approved a new drug for pancreatic cancer. The Food and Drug Administration (FDA) announced the approval, which introduces a different method for treating the illness. The drug functions by blocking a protein that contributes to tumor growth. This protein is present in most pancreatic cancer cases. The new treatment targets this specific mechanism.